INVESTIGADORES
CHEHIN Rosana Nieves
artículos
Título:
The chemically-modified tetracycline col-3 and its parent compound doxycycline prevent microglial inflammatory re-sponses by reducing glucose-mediated oxidative stress
Autor/es:
FERREIRA JUNIOR, NILSON CARLOS; DOS SANTOS PEREIRA, MAURÍCIO; FRANCIS, NOUR; RAMIREZ, PAOLA; MARTORELL, PAULA; GONZÁLEZ-LIZARRAGA, FLORENCIA; FIGADÈRE, BRUNO; CHEHIN, ROSANA; DEL BEL, ELAINE; RAISMAN-VOZARI, RITA; MICHEL, PATRICK PIERRE
Revista:
Cells
Editorial:
MDPI
Referencias:
Año: 2021 vol. 10
Resumen:
We used mouse microglial cells in culture activated by lipopolysaccharide (LPS) or α-synuclein amyloid aggregates (αSa) to study the anti-inflammatory effects of COL-3, a tetracycline derivative without antimicrobial activity. Under LPS or αSa stimulation, COL-3 (10, 20 µM) efficiently repressed the induction of the microglial activation marker protein Iba-1 and the stimulated-release of the pro-inflammatory cytokine TNF-α. COL-3′s inhibitory effects on TNF-α were reproduced by the tetracycline antibiotic doxycycline (DOX; 50 µM), the glucocorticoid dexamethasone, and apocynin (APO), an inhibitor of the superoxide-producing enzyme NADPH oxidase. This last observation suggested that COL-3 and DOX might also operate themselves by restraining oxidative stress-mediated signaling events. Quantitative measurement of intracellular reactive oxygen species (ROS) levels revealed that COL-3 and DOX were indeed as effective as APO in reducing oxidative stress and TNF-α release in activated microglia. ROS inhibition with COL-3 or DOX occurred together with a reduction of microglial glucose accumulation and NADPH synthesis. This suggested that COL-3 and DOX might reduce microglial oxidative burst activity by limiting the glucose-dependent synthesis of NADPH, the requisite substrate for NADPH oxidase. Coherent with this possibility, the glycolysis inhibitor 2-deoxy-D-glucose reproduced the immunosuppressive action of COL-3 and DOX in activated microglia. Overall, we propose that COL-3 and its parent compound DOX exert anti-inflammatory effects in microglial cells by inhibiting glucose-dependent ROS production. These effects might be strengthened by the intrinsic antioxidant properties of DOX and COL-3 in a self-reinforcing manner.